Clinical Trials Logo

Healthy Volunteers clinical trials

View clinical trials related to Healthy Volunteers.

Filter by:

NCT ID: NCT00784420 Completed - Healthy Volunteers Clinical Trials

Drug Interaction Study Between Raltegravir And UK-453,061

Start date: September 2008
Phase: Phase 1
Study type: Interventional

The purpose of this study is to estimate the effect of steady state raltegravir on the steady state pharmacokinetics of UK-453,061 and steady state UK-453,061 on the steady state pharmacokinetics of raltegravir.

NCT ID: NCT00783484 Completed - Healthy Volunteers Clinical Trials

A Study To Evaluate The Safety, Tolerability And Pharmacokinetics Of Single Oral Doses Of PF-03716539 In Healthy Adult Subjects

Start date: October 2008
Phase: Phase 1
Study type: Interventional

First in human study to evaluate the safety, tolerability, and pharmacokinetics of PF-03716539. The potential of PF-03716539 to increase the concentrations of midazolam, darunavir and maraviroc will also be evaluated.

NCT ID: NCT00781144 Completed - Healthy Volunteers Clinical Trials

Determination of Forces Used in Palpatory Diagnosis

Start date: August 2007
Phase: N/A
Study type: Observational

In this study, we are experimentally investigating the assessment of forces used by skilled clinicians and beginning practitioners in palpatory techniques. The study will assess pressure used during palpatory diagnosis of the paraspinal region.

NCT ID: NCT00773201 Completed - Healthy Volunteers Clinical Trials

Genetic Sources of Variability of the Adaptation of the Ventricular Repolarisation

Generepol
Start date: February 2008
Phase: Phase 1
Study type: Interventional

The main objective is to research for genetic factors involved in the extreme modifications of the QT interval of the electrocardiogram in answer to a pharmacological stimulation (sotalol) and physiological stimulation in the apparently normal general population. The phenotypic characterization, based on the ventricular repolarisation dynamics will be used aiming at term of the predictive genetic factors of the acquired long QT syndrome

NCT ID: NCT00769899 Completed - Healthy Volunteer Clinical Trials

AZD7325 Single Ascending Dose Study in Healthy Male Japanese Subjects

JSAD
Start date: October 2008
Phase: Phase 1
Study type: Interventional

This is a Phase I randomized double-blind, placebo-controlled, single centre study to assess the safety, tolerability and pharmacokinetics of AZD7325 following single ascending dose administration to healthy male Japanese volunteers.

NCT ID: NCT00767676 Completed - Healthy Volunteers Clinical Trials

Contact Sensitization Potential of 828 Ointment

Start date: October 2008
Phase: Phase 1
Study type: Interventional

Contact sensitization by patch applications.

NCT ID: NCT00767455 Completed - Healthy Volunteers Clinical Trials

Cumulative Irritation Potential of 828 Ointment

Start date: October 2008
Phase: Phase 1
Study type: Interventional

Cumulative Irritation Patch Test

NCT ID: NCT00767052 Completed - Healthy Volunteer Clinical Trials

Investigate the Safety Tolerability and Pharmacokinetics of Multiple Doses of AZD1236

Start date: September 2008
Phase: Phase 1
Study type: Interventional

The purpose of this study is to investigate the safety, tolerability and pharmacokinetics of multiple ascending oral doses of AZD1236 given to healthy young subjects for 13 days and to evaluate the single-dose relative bioavailability of the oral suspension and oral tablet formulations.

NCT ID: NCT00765492 Completed - Healthy Volunteer Clinical Trials

AZD8529 Multiple Ascending Dose Study in Healthy Subjects

Start date: October 2008
Phase: Phase 1
Study type: Interventional

This is a study to evaluate safety, tolerability, PK and PD effects of orally administered AZD8529 after multiple ascending doses

NCT ID: NCT00761501 Completed - Healthy Volunteer Clinical Trials

Phase I Study to Evaluate Bioavailability of Naproxen as PN400 Compared to Naproxen as Proxen S and Naprosyn E

Start date: September 2008
Phase: Phase 1
Study type: Interventional

The purpose of the study is to investigate the uptake in the body of naproxen; one of the two active substances in PN400. We also want to show that the body's uptake of naproxen given as PN400 is comparable to that of currently marketed naproxen tablets.